Hereditary Cancer in Clinical Practice | |
Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk | |
Gloria M Petersen5  Carmen Radecki Breitkopf2  Kari G Rabe3  Ashley Nadeau3  Shawna L Ehlers1  Paul A Decker3  Christi A Patten4  Tabetha A Brockman4  Pamela S Sinicrope4  Lisa A Howell1  | |
[1] Department of Psychology and Psychiatry, Mayo Clinic Rochester, Rochester, MN, USA;Division of Health Care Policy & Research, Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, MN, USA;Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, MN, USA;Behavioral Health Research Program, Mayo Clinic Rochester, Rochester, MN, USA;Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, MN, USA | |
关键词: Lifestyle; Risk reduction; Perceived risk; Health behavior change; Family; Pancreatic cancer; | |
Others : 806151 DOI : 10.1186/1897-4287-11-3 |
|
received in 2012-11-06, accepted in 2013-05-21, 发布年份 2013 | |
【 摘 要 】
Background
Cancer is a shared family experience that might provide an opportunity for lifestyle change among at-risk family members. The purpose of this study was to assess receptivity and preferences for cancer risk reduction programs among at-risk family members with two or more relatives affected with pancreas cancer.
Methods
We surveyed 401 at-risk family members in an existing pancreatic cancer family registry. Participants completed a mailed survey which examined demographic, medical, and psychosocial correlates of willingness to participate in lifestyle cancer risk reduction programs. Multivariable generalized estimating equation approaches were used to model preferences.
Results
Overall, 85% (n = 342) of at-risk family members were receptive to lifestyle cancer risk reduction programs. Participant preferred programs focused on nutrition (36%, n = 116) and weight management (33%, n = 108), with Web/Internet (46%, n = 157) being the most preferred delivery channel. Most respondents preferred to participate in programs with their family or friends (74%, n = 182), rather than alone (25%, n = 85). In multivariable analysis, younger age (p = 0.008) and higher perceived likelihood of developing cancer (p = 0.03) were associated with willingness to participate in lifestyle programs.
Conclusions
Family members of those with pancreatic cancer are receptive to cancer risk reduction programs focusing on nutrition and weight management delivered via the internet. Further research is indicated to determine how to best incorporate a family-based approach when designing lifestyle intervention programs.
【 授权许可】
2013 Howell et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140708090830264.pdf | 188KB | download |
【 参考文献 】
- [1]Petrin K, Bowen DJ, Alfano CM, Bennett R: Adjusting to pancreatic cancer: perspectives from first-degree relatives. Palliat Support Care 2009, 7(3):281-288.
- [2]American Cancer Society (ACS): Cancer fact and figures 2010. 2010. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf webcite. Accessed March 10 2011
- [3]Baum A, Andersen BL: Psychosocial interventions for cancer. Washington, DC, US: American Psychological Association; 2001.
- [4]Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P: Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993, 85(13):1074-1080.
- [5]Hart AR, Kennedy H, Harvey I: Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008, 6(3):275-282.
- [6]Steinberg WM, Barkin JS, Bradley EL 3rd, DiMagno E, Layer P, Canto MI, Levy MJ: Should patients with a strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas? Pancreas 2009, 38(5):e137-e150.
- [7]Anderson LN, Cotterchio M, Gallinger S: Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario Canada. Cancer Causes Control 2009, 20(6):825-834.
- [8]Giovannucci E, Michaud D: The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007, 132(6):2208-2225.
- [9]Larsson SC, Orsini N, Wolk A: Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 2007, 120(9):1993-1998.
- [10]Luo J, Iwasaki M, Inoue M, Sasazuki S, Otani T, Ye W, Tsugane S: Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan–the JPHC study. Cancer Causes Control 2007, 18(6):603-612.
- [11]Kristeller JL, Hebert J, Edmiston K, Liepman M, Wertheimer M, Ward A, Luippold R: Attitudes toward risk factor behavior of relatives of cancer patients. Prev Med 1996, 25(2):162-169.
- [12]Lemon SC, Zapka JG, Clemow L: Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med 2004, 39(2):253-262.
- [13]Carlos RC, Dempsey AF, Patel DA, Dalton VK: Cervical cancer prevention through human papillomavirus vaccination: using the "teachable moment" for educational interventions. Obstet Gynecol 2010, 115(4):834-838.
- [14]McBride CM, Ostroff JS: Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003, 10(4):325-333.
- [15]Sutherland G, White V: Teachable moments in diet and nutrition for family and friends calling the Cancer Helpline. Aust N Z J Public Health 2005, 29(4):388-389.
- [16]Baider L, Surbone A: Cancer and the family: the silent words of truth. J Clin Oncol 2010, 28(7):1269-1272.
- [17]Garces YI, Patten CA, Sinicrope PS, Decker PA, Offord KP, Brown PD, Clark MM, Rummans TA, Foote RL, Hurt RD: Willingness of cancer patients to help family members to quit smoking. Psychooncology 2011, 20(7):724-729.
- [18]McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM: Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008, 68(12):4928-4935.
- [19]Faschingbauer T, Zisook S, DeVaul R: The Texas revised inventory of grief. In Biopsychosocial Aspects of Breavement. Edited by Zisook S. Washington, DC: American Psychiatric Press; 1987:111-124.
- [20]Jerusalem M, Schwarzer R: Self-efficacy as a resource factor in stress appraisal process. In Self-efficacy: Thought control of action. Edited by Schwarzer R. Washington, D.C: Hemisphere; 1992:195-213.
- [21]Schwarzer R, Renner B: Health Specific Self-Efficacy Scales. Berlin: Germany; 1996.
- [22]Marcus BH, Selby VC, Niaura RS, Rossi JS: Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992, 63(1):60-66.
- [23]Godin G, Shephard RJ: A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985, 10(3):141-146.
- [24]Cohen S: Social relationships and health. Am Psychol 2004, 59(8):676-684.
- [25]Hay JL, Buckley TR, Ostroff JS: The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005, 14(7):517-534.
- [26]Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR: Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol 2007, 25(11):1403-1411.
- [27]Hawkins NA, McCarty F, Peipens LA, Rodriquez JL: Measuring the degree of closeness to the cancer experience: development and initial validation of the CONNection to the Experience of Cancer Scale (CONNECS). Patient Educ Counseling 2012, 89(2):292-299.
- [28]Gulanick M, Bliley A, Perino B, Keough V: Recovery patterns and lifestyle changes after coronary angioplasty: the patient's perspective. Heart Lung 1998, 27(4):253-262.
- [29]Speechly C, Bridges-Webb C, McKenzie S, Zurynski Y, Lucas A: Patient and general practitioner attitudes to healthy lifestyle behaviours and medication following coronary heart disease: an exploratory study. Aus J Primary Health 2010, 16(2):154-158.